Literature DB >> 2682866

Mucus as a natural barrier.

M T Lopez-Vidriero1.   

Abstract

The airway mucus varies in amount, composition and physical properties at different levels of the airways and thus variation in types and/or degree of defence are expected. The mucus barrier, that is the barrier provided by the secretory products from the mucous membrane, comprises three compartments: the epiphase (gel layer); the hypophase (sol layer), and the glycocalyx. The epiphase is the best characterized of the three and, because of its direct contact with the external environment, is the more complex and can act as a physical, chemical and biological barrier. The hypophase and the glycocalyx barriers are less well known in terms of composition, origin, control and functions. The periciliary/sol layer, apart from providing a suitable environment for the cilia, can further dilute substances which have crossed the gel layer. The glycocalyx represents the last protective barrier for the cell membrane and is likely to play an important role in the defence of the surface epithelium. A better understanding of their origin, composition and control, both in health and disease, will help us to choose the appropriate therapeutic agent for enhancing their efficacy as natural barriers.

Mesh:

Year:  1989        PMID: 2682866     DOI: 10.1159/000195748

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways.

Authors:  M Kesimer; C Ehre; K A Burns; C W Davis; J K Sheehan; R J Pickles
Journal:  Mucosal Immunol       Date:  2012-08-29       Impact factor: 7.313

Review 2.  Virus infection of polarized epithelial cells.

Authors:  S P Tucker; R W Compans
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

3.  Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors.

Authors:  G Wang; G Williams; H Xia; M Hickey; J Shao; B L Davidson; P B McCray
Journal:  Gene Ther       Date:  2002-07       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.